Initiating continuous glucose monitoring is associated with improvements in glycemic control and reduced health care resource utilization for people with diabetes in a large US-insured population: A real-world evidence study

We looked at the way continuous glucose monitoring (CGM) devices affect blood sugar tests (hemoglobin A1c) and use of medical services. We studied insurance data from a group of people with diabetes in a large health care system. After they started using the device, people with diabetes had better A...

Full description

Saved in:
Bibliographic Details
Published in:Journal of managed care & specialty pharmacy 2025-01, Vol.31 (1), p.15-24
Main Authors: Norman, Gregory J., Fernandes, Joaquim, Nemlekar, Poorva, Andrade, Sarah B., Lupton, Laura, Berk, Alexa
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We looked at the way continuous glucose monitoring (CGM) devices affect blood sugar tests (hemoglobin A1c) and use of medical services. We studied insurance data from a group of people with diabetes in a large health care system. After they started using the device, people with diabetes had better A1c results and fewer hospital stays and emergency department visits. This study showed that CGM use in patients with diabetes was associated with clinically meaningful improvements in A1c and reduced health care resource utilization. Notably, patients with type 2 diabetes not treated with insulin experienced significantly improved A1c outcomes. Results from this study contribute to the growing evidence supporting the expansion of access to CGM technology for all people with diabetes, regardless of insulin therapy regimen.
ISSN:2376-0540
2376-1032
DOI:10.18553/jmcp.2024.24255